Richter, S., Seah, J.-A., Pond, G. R., Gan, H. K., Mackenzie, M. J., Hotte, S. J., Mukherjee, S. D., Murray, N., Kollmannsberger, C., Heng, D., Haider, M. A., Halford, R., Ivy, S. P., Moore, M. J., & Sridhar, S. S. (2014). Evaluation of second line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first line cediranib. Canadian Urological Association Journal, 8(11-12), 398–402. https://doi.org/10.5489/cuaj.2426